Redeye reinforces its positive view of CombinedX following a strong Q2 report. The organic growth was 6.6%, and the EBIT margin was 10.1% despite the tough calendar. Although the company experiences softness in some sectors, CombinedX has compensated by increasing sales to strong sectors, such as industrials.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

CombinedX - Solid Momentum Continued

© Modular Finance, source Nordic Press Releases